Medicare Enrolled
Dr. Anthony Malvasi, D.O.
Student in an Organized Health Care Education/Training Program · East Syracuse, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Malvasi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Malvasi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Malvasi
Dr. Anthony Malvasi is a student in an organized health care education/training program specialist in East Syracuse, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Malvasi performed 1,268 Medicare services across 855 unique beneficiaries.
Between the years covered by Open Payments, Dr. Malvasi received a total of $13,196 from 59 pharmaceutical and/or device companies across 965 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Malvasi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 13% volume in NY
$13,196 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,268
Medicare services
Top 13% in NY for student in an organized health care education/training program
855
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~91 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
241 | $62 | $130 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
190 | $8 | $25 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
170 | $10 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
132 | $80 | $180 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
108 | $7 | $30 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
105 | $13 | $35 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
49 | $3 | $15 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
44 | $10 | $25 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
41 | $124 | $200 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
32 | $9 | $28 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
32 | $16 | $40 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
28 | $17 | $90 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
23 | $10 | $75 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
14 | $139 | $318 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
13 | $50 | $80 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
12 | $12 | $25 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
12 | $19 | $65 |
| Influenza virus nucleic acid detection test A laboratory test that uses nucleic acid technology to detect multiple types of influenza virus. |
11 | $94 | $190 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $30 | $55 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,196
Total received (2018-2024)
Avg $1,885/year across 7 years
Top 4% in NY for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
965
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,196 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,552
2023
$1,650
2022
$2,015
2021
$2,666
2020
$1,147
2019
$1,023
2018
$2,145
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$354
PFIZER INC.
$350
Amgen Inc.
$305
Lilly USA, LLC
$224
ABBVIE INC.
$177
Novartis Pharmaceuticals Corporation
$173
Bayer Healthcare Pharmaceuticals Inc.
$127
Daiichi Sankyo Inc.
$114
Astellas Pharma US Inc
$100
Novo Nordisk Inc
$86
Exact Sciences Corporation
$80
Insulet Corporation
$76
Janssen Pharmaceuticals, Inc
$70
GlaxoSmithKline, LLC.
$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$46
SHIELD THERAPEUTICS INC
$38
Esperion Therapeutics, Inc.
$32
UCB, Inc.
$29
SANOFI-AVENTIS U.S. LLC
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Teva Pharmaceuticals USA, Inc.
$17
IRONWOOD PHARMACEUTICALS, INC
$15
Collegium Pharmaceutical, Inc.
$14
Paratek Pharmaceuticals, Inc.
$13
Top 3 companies account for 39.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,054
Lilly USA, LLC
$918
ABBVIE INC.
$804
Teva Pharmaceuticals USA, Inc.
$782
AbbVie Inc.
$772
PFIZER INC.
$767
Amarin Pharma Inc.
$766
Novo Nordisk Inc
$741
Amgen Inc.
$739
GlaxoSmithKline, LLC.
$707
Astellas Pharma US Inc
$672
Takeda Pharmaceuticals U.S.A., Inc.
$466
Biohaven Pharmaceuticals, Inc.
$295
Janssen Pharmaceuticals, Inc
$278
Boehringer Ingelheim Pharmaceuticals, Inc.
$261
Biohaven Pharmaceutical Holding Company Ltd.
$235
Merck Sharp & Dohme Corporation
$203
Bayer Healthcare Pharmaceuticals Inc.
$195
Allergan Inc.
$194
Novartis Pharmaceuticals Corporation
$186
Exact Sciences Corporation
$174
Daiichi Sankyo Inc.
$168
MannKind Corporation
$167
Bayer HealthCare Pharmaceuticals Inc.
$141
ARBOR PHARMACEUTICALS, INC.
$140
Allergan, Inc.
$135
Shire North American Group Inc
$130
Celgene Corporation
$83
Insulet Corporation
$76
ITI, Inc.
$73
UCB, Inc.
$68
SANOFI-AVENTIS U.S. LLC
$65
Merck Sharp & Dohme LLC
$64
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$54
Esperion Therapeutics, Inc.
$53
Corium, LLC
$48
Kowa Pharmaceuticals America, Inc.
$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$46
Eisai Inc.
$42
SHIELD THERAPEUTICS INC
$38
Almatica Pharma LLC
$36
Mannkind Corporation
$34
Genentech USA, Inc.
$34
Collegium Pharmaceutical, Inc.
$28
Dexcom, Inc.
$21
DEXCOM, INC.
$20
MEDICOMP INC
$18
E.R. Squibb & Sons, L.L.C.
$17
IDORSIA PHARMACEUTICALS US INC
$16
IBSA Pharma Inc.
$15
IRONWOOD PHARMACEUTICALS, INC
$15
Otsuka America Pharmaceutical, Inc.
$14
Paratek Pharmaceuticals, Inc.
$13
Synergy Pharmaceuticals Inc
$13
Nestle HealthCare Nutrition Inc.
$13
Sunovion Pharmaceuticals Inc.
$13
AbbVie, Inc.
$11
Gilead Sciences, Inc.
$11
Neuronetics, Inc.
$7
Top 3 companies account for 21.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · AIRSUPRA · AJOVY · ANORO ELLIPTA · AREXVY · AUSTEDO · Aimovig · AirDuo Digihaler · Ajovy · Austedo XR · Azstarys · BAQSIMI · BELSOMRA · BEXSERO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Belbuca · CAPLYTA · CHANTIX · COLOGUARD · COMIRNATY · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · Evekeo · FARXIGA · GARDASIL 9 · GLYXAMBI · GRALISE · HUMIRA · Horizant · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LYRICA · Levemir · Linzess · Livalo · MOUNJARO · MYDAYIS · MYRBETRIQ · Myrbetriq · NAPRELAN · NEUROSTAR TMS THERAPY · NEXLETOL · NEXLIZET · NURTEC ODT · NUZYRA · Nayzilam · Omnipod · Otezla · Otovel · Ozempic · PRALUENT · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · ROTATEQ · RYBELSUS · Repatha · Rybelsus · Rystiggo · SHINGRIX · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SYNTHROID · Saxenda · Synthroid · TELEPATCH CARDIAC MONITOR · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · TZIELD · Tirosint · Tresiba · Trintellix · Trulance · UBRELVY · Utibron · VESICARE · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · XTAMPZA · Xofluza · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for student in an organized health care education/training program in NY.
Geographic Context
Student in an organized health care education/training programs within 10 mi
1,408
Per 100K population
298.6
County median income
$74,740
Nearest hospital
ST JOSEPH'S HOSPITAL HEALTH CENTER
5.7 mi
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Malvasi is a clinical cardiology specialist, with above-average Medicare volume (top 13% in NY), with low-engagement industry engagement in the top 4% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Malvasi experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Malvasi performed 241 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Malvasi receive payments from pharmaceutical companies?
Yes. Dr. Malvasi received a total of $13,196 from 59 companies across 965 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Malvasi's costs compare to other student in an organized health care education/training programs in East Syracuse?
Dr. Malvasi's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Malvasi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in East Syracuse
Browse student in an organized health care education/training programs in East Syracuse ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in NY
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in NY
Which NY student in an organized health care education/training programs receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology